Research Catalog

Improving Regulatory Transparency for New Medical Therapies Act : report (to accompany H.R. 4299) (including cost estimate of the Congressional Budget Office).

Title
Improving Regulatory Transparency for New Medical Therapies Act : report (to accompany H.R. 4299) (including cost estimate of the Congressional Budget Office).
Author
United States. Congress. House. Committee on Energy and Commerce, author.
Publication
[Washington, D.C.] : [U.S. Government Printing Office], [2014]-

Available Online

  • PDF version:
  • Text version:

Details

Additional Authors
United States. Congress. House. Committee on the Judiciary, author.
Description
1 online resource (volumes).
Series Statement
  • Report / 113th Congress, 2d session, House of Representatives ; 113-565
  • United States. Congress. House. Report ; 113-565.
Subject
  • Drugs of abuse > Law and legislation > United States
  • Drug approval > United States
Genre/Form
Legislative materials.
Note
  • Title from pt. 1 title screen (viewed on Aug. 4, 2014).
  • Title from pt. 2 title screen (viewed on Oct. 8, 2014).
  • "Committee on the Judiciary"--Pt. 2.
  • "July 29, 2014"--Pt. 1.
  • "September 19, 2014"--Pt. 2.
Call Number
GPO Internet Y 1.1/8:113-565
OCLC
marcive885196378
Author
United States. Congress. House. Committee on Energy and Commerce, author.
Title
Improving Regulatory Transparency for New Medical Therapies Act : report (to accompany H.R. 4299) (including cost estimate of the Congressional Budget Office).
Publisher
[Washington, D.C.] : [U.S. Government Printing Office], [2014]-
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Series
Report / 113th Congress, 2d session, House of Representatives ; 113-565
United States. Congress. House. Report ; 113-565.
Connect to:
PDF version:
Text version:
Added Author
United States. Congress. House. Committee on the Judiciary, author.
Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. Improving Regulatory Transparency for New Medical Therapies Act (OCoLC)886532540
Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Improving Regulatory Transparency for New Medical Therapies Act (OCoLC)896174076
Gpo Item No.
1008-I (online)
Sudoc No.
Y 1.1/8:113-565/
View in Legacy Catalog